A clinical trial of using antiplatelet therapy to prevent restenosis following peripheral artery angioplasty and stenting

National Medical Journal of China

Volumn 88, Issue 12, 2008, Pages 812-815

  Tan, Jin Yun ^a   Shi, Wei Hao ^a   He, Jing ^a   Zhu, Lei ^a   Wang, Tie Ping ^a   Yu, Bo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Catheterization, peripheral; Stents; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ANTICOAGULANT THERAPY; ARTERY REOCCLUSION; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD ANALYSIS; BLOOD CLOTTING TEST; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STENT; SURGICAL MORTALITY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIOSCLEROSIS OBLITERANS; ASPIRIN; CATHETERIZATION, PERIPHERAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 44449178404     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sabeti S, Mlekusch W, Amighi J, et al. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther, 2005,12:6-12.
2. Dörffler-Melly J, Koopman MM, Prins MH, et al. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev, 2005,25:CD002071.
3. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/ reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg, 1997,25:74-83.
4. Schweizer J, Muller A, Forkman L, et al. Potential use of a low-molecular-weight heparin to prevent restenosis in patients with extensive wall damage following peripheral angioplasty. Angiology, 2001,52:659-669.
5. Dörffler-Melly J, Mahler F, Do DD, et al. Adjunctive abciximab improves patency and functional outcome in endovascular treatment of femoropopliteal occlusions: initial experience. Radiology, 2005, 273:1103-1109.
6. Vogel TR, Shindelman LE, Nackman GB, et al. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg, 2003,38:1178-1184.
7. Smith SC, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2006, 113:166-286.
8. Strecker EP, Boos IB, Gottmann D, et al. Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results. Eur Radiol, 2004,14:302-308.
9. Chinese source.
10. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting the full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study. Circulation, 1998,98:1597-1603.
11. Chinese source.
12. Horton JD, Bushwick BM. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician, 1999,59:635-646.